Home >> WEBINARS >> Why DMTs are a critical ingredient in the delivery of value-based care

Why DMTs are a critical ingredient in the delivery of value-based care

Print Friendly, PDF & Email

Tuesday, March 5, 2019, 1PM–2PM ET

Dr. Laposata

Dr. Friedman

Webinar presenters Michael Laposata, MD, PhD, University of Texas Medical Branch at Galveston Pathology, Chairman, and Bruce Friedman, MD, University of Michigan, Pathology, Emeritus Professor, Informatics, will discuss the barriers that exist for the rapid and significant growth of diagnostic management teams to reduce medical error and optimize laboratory test use, overcoming barriers to DMT implementation, addressing connectivity between experts and doctors, and identifying ways to overcome DMT resistance from your peers. Ask your questions of our distinguished presenters.

This webinar will also be hosted before a live audience at DMT Conference Galveston Island Convention Center, Galveston, Texas.

Moderated by: Bob McGonnagle, Publisher, CAP TODAY

Register Now

CAP TODAY does not endorse any of the products or services named within.
The webinar is made possible by a special educational grant from Roche.

X